Sneha Rangu1, Leslie Castelo-Soccio1,2. 1. Section of Dermatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 2. University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract
BACKGROUND: Trichotillomania (TTM) is a complex disease with varying clinical characteristics, and psychosocial impairment is noted in many TTM patients. Despite its prevalence in childhood, there is limited research on pediatric TTM. OBJECTIVE: To analyze the clinical and epidemiologic features of TTM in children evaluated by dermatologists and behavioral health specialists. METHOD: We performed a retrospective chart review of 137 pediatric patients seen at the Children's Hospital of Philadelphia with initial presentation of TTM at age 17 or younger. Patients were treated by dermatology or behavioral health. RESULTS: The majority of the patients were females, with an average diagnosis age around 8 years. Over half had a psychiatric comorbidity, and over a quarter had a skin disorder. Skin disorders were more commonly present in those evaluated by dermatology, and psychiatric comorbidities were more commonly present in those evaluated by behavioral health. The most common form of treatment was behavioral therapy, with medications prescribed more often by dermatologists. CONCLUSIONS: TTM patients choose to present to behavioral health or dermatology; however, there are distinctive differences between the two cohorts. With behavioral and pharmacologic treatment options, a relationship between dermatologists and behavioral health specialists is necessary for multifactorial management of TTM.
BACKGROUND: Trichotillomania (TTM) is a complex disease with varying clinical characteristics, and psychosocial impairment is noted in many TTM patients. Despite its prevalence in childhood, there is limited research on pediatric TTM. OBJECTIVE: To analyze the clinical and epidemiologic features of TTM in children evaluated by dermatologists and behavioral health specialists. METHOD: We performed a retrospective chart review of 137 pediatric patients seen at the Children's Hospital of Philadelphia with initial presentation of TTM at age 17 or younger. Patients were treated by dermatology or behavioral health. RESULTS: The majority of the patients were females, with an average diagnosis age around 8 years. Over half had a psychiatric comorbidity, and over a quarter had a skin disorder. Skin disorders were more commonly present in those evaluated by dermatology, and psychiatric comorbidities were more commonly present in those evaluated by behavioral health. The most common form of treatment was behavioral therapy, with medications prescribed more often by dermatologists. CONCLUSIONS: TTM patients choose to present to behavioral health or dermatology; however, there are distinctive differences between the two cohorts. With behavioral and pharmacologic treatment options, a relationship between dermatologists and behavioral health specialists is necessary for multifactorial management of TTM.
Authors: Luis C Farhat; Emily Olfson; Jessica L S Levine; Fenghua Li; Martin E Franklin; Han-Joo Lee; Adam B Lewin; Joseph F McGuire; Omar Rahman; Eric A Storch; David F Tolin; Hana F Zickgraf; Michael H Bloch Journal: J Child Adolesc Psychopharmacol Date: 2019-12-02 Impact factor: 2.576
Authors: Emily J Ricketts; Ivar Snorrason; Katharina Kircanski; Jennifer R Alexander; Jordan T Stiede; Hardian Thamrin; Christopher A Flessner; Martin E Franklin; Nancy J Keuthen; Michael R Walther; John Piacentini; Dan J Stein; Douglas W Woods Journal: Ann Clin Psychiatry Date: 2019-08 Impact factor: 2.691